Methadone in pregnancy: clinical-toxicological aspects

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Clinical Toxicology

Background:

• Opioid use during pregnancy poses significant risks to both mother and fetus.
• Methadone maintenance treatment is a common approach for pregnant women with opioid use disorder.
• Managing neonatal outcomes requires careful obstetrical and toxicological monitoring.

Purpose of the Study:

• To evaluate the outcomes of methadone treatment in pregnant women.
• To assess the effects of methadone on newborns.
• To determine the role of toxicological monitoring in managing drug-dependent pregnant women.

Main Methods:

• A study involving thirteen pregnant women undergoing methadone treatment.
• Defined obstetrical and toxicological protocols were followed.
• Newborns of treated mothers were included in the assessment.

Main Results:

• Low-dose methadone (5 mg/day) during labor minimized neonatal toxicological risk in some cases.
• Pharmacological management effectively controlled neonatal withdrawal syndrome.
• The toxicological laboratory played a crucial role in clinical management.

Conclusions:

• Methadone treatment can be managed safely during pregnancy with adherence to protocols.
• Minimizing methadone dosage during labor can reduce neonatal risks.
• Integrated toxicological and clinical care is vital for drug-dependent pregnant women.